NERVGEN PHARMA CORP. Form 6-K — Sep 24, 2026
NervGen Pharma announced a change of auditor effective September 15, 2026, with KPMG Canada resigning at the company's request and KPMG US appointed to fill the vacancy. The change was approved by the audit committee and board of directors, and the company confirmed there were no modified audit opinions or reportable events over the past two financial years.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.